Insider Profile
DELANEY, KEVIN M.
1
Companies Filed At
0
Open-Market Buys (2yr)
—
Buy Value (2yr, open-market)
Mar 07, 2022
Most Recent Trade
11
Credibility
Score
14%
Hit Rate
-4.8%
Avg 90d Return
-7.9%
Median 90d Return
14
Evaluated Trades
+23.7%
Best Trade
-12.8%
Worst Trade
Hit rate and returns are based on 14 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Date Company Role Nature Dir. Shares Price Value Score
Mar 07, 2022 $IMAX
IMAX Corporation
— Comp. Grant Buy 5,566 — — 73
Mar 07, 2022 $IMAX
IMAX Corporation
— Exercise Sell 1,706 — — 73
Mar 07, 2022 $IMAX
IMAX Corporation
— Exercise Sell 1,885 — — 73
Mar 07, 2022 $IMAX
IMAX Corporation
— Exercise Sell 2,526 — — 73
Mar 07, 2022 $IMAX
IMAX Corporation
— Comp. Grant Buy 1,855 — — 73
Mar 07, 2022 $IMAX
IMAX Corporation
— Buyback Buy 706 $18.13 $13K 73
Mar 07, 2022 $IMAX
IMAX Corporation
— Exercise Buy 1,706 — — 73
Mar 07, 2022 $IMAX
IMAX Corporation
— Buyback Buy 780 $18.13 $14K 73
Mar 07, 2022 $IMAX
IMAX Corporation
— Exercise Buy 1,885 — — 73
Mar 07, 2022 $IMAX
IMAX Corporation
— Buyback Buy 1,070 $18.13 $19K 73
Mar 07, 2022 $IMAX
IMAX Corporation
— Exercise Buy 2,526 — — 73
Mar 07, 2021 $IMAX
IMAX Corporation
— Exercise Sell 2,526 — — 73
Mar 07, 2021 $IMAX
IMAX Corporation
— Buyback Buy 1,009 $24.59 $25K 73
Mar 07, 2021 $IMAX
IMAX Corporation
— Exercise Buy 2,526 — — 73
Mar 07, 2021 $IMAX
IMAX Corporation
— Comp. Grant Buy 8,888 — — 73
Mar 07, 2021 $IMAX
IMAX Corporation
— Comp. Grant Buy 1,706 — — 73
Mar 12, 2020 $IMAX
IMAX Corporation
— Comp. Grant Buy 2,526 — — 73
Mar 12, 2020 $IMAX
IMAX Corporation
— Comp. Grant Buy 7,580 — — 73
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.